Envarsus Designated Orphan Drug for Kidney Transplant Rejection Prophylaxis Monthly Prescribing Reference ... Drug for Kidney Transplant Rejection Prophylaxis. Veloxis announced that the FDA has granted Orphan Drug designation to Envarsus (tacrolimus; formerly LCP-Tacro) for prophylaxis of organ rejection in patients receiving allogenic kidney transplants. FDA grants orphan drug designation to Veloxis' kidney transplant drug |
